TRIO Obtains the Great Place to Work® Certification in Uruguay
April 11, 2022 09:30 ET | Translational Research in Oncology
-100% of employees consider TRIO Uruguay a great place to work- MONTEVIDEO, Uruguay, April 11, 2022 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global oncology clinical...
TRIO recebe certificação Great Place to Work® no Uruguai
April 11, 2022 09:30 ET | Translational Research in Oncology
-100% dos funcionários consideram o TRIO Uruguai um ótimo lugar para trabalhar- MONTEVIDÉU, Uruguai, April 11, 2022 (GLOBE NEWSWIRE) -- A Translational Research in Oncology (TRIO), uma...
TRIO obtiene la certificación de Great Place to Work® en Uruguay
April 11, 2022 09:30 ET | Translational Research in Oncology
-El 100% de los empleados considera que TRIO Uruguay es un gran lugar para trabajar- MONTEVIDEO, Uruguay, April 11, 2022 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), una...
trio.jpg
Trio Named To Canada’s Top Employer List For Second Straight Year
April 06, 2022 11:41 ET | Translational Research in Oncology
- Third Time Named to Alberta’s Top Employer List - EDMONTON, April 06, 2022 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO), a global academic clinical research organization, is...
trio.jpg
TRIO Enrols First Patient in Global Phase 3 Giredestrant Early Breast Cancer Trial
August 31, 2021 09:00 ET | Translational Research in Oncology
EDMONTON, Alberta, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of first patient in the...
trio.jpg
TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule
July 06, 2021 07:00 ET | Translational Research in Oncology
EDMONTON, Alberta, July 06, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment completion in coopERA...
trio.jpg
Translational Research in Oncology (TRIO) Appoints Board Member
May 20, 2021 09:00 ET | Translational Research in Oncology
EDMONTON, Alberta, May 20, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced the appointment of Prof. Seock-Ah Im...
trio.jpg
TRIO Completes Enrollment of Phase III NATALEE Breast Cancer Clinical Trial
April 21, 2021 08:00 ET | Translational Research in Oncology
EDMONTON, Alberta, April 21, 2021 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced completion of enrollment for Novartis phase III clinical trial of ribociclib with...
trio.jpg
Translational Research in Oncology (TRIO) Named Top Alberta Employer for Second Year
January 26, 2021 14:25 ET | Translational Research in Oncology
EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, is pleased to be recognized as one of Alberta’s Top...
trio.jpg
Translational Research in Oncology (TRIO) Enrolls First Patient in Early Breast Cancer Phase 2 Trial
September 15, 2020 09:00 ET | Translational Research in Oncology
EDMONTON, Alberta, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, announced today enrolment of the first patient in a...